You are here

lupus

One year after flop, AstraZeneca's phase 3 lupus trial hits endpoint

Fierce Biotech

Thu, 08/29/19 - 10:30 am

clinical trials

systemic lupus erythematosus

Beyond cancer: CAR T cells treat lupus in mice

BioCentury

Thu, 03/7/19 - 09:30 pm

Biogen sees two phase 2 failures: In sciatica and in its lupus collaboration with UCB

Fierce Biogen

Tue, 10/23/18 - 01:40 pm

dapirolizumab pegol

UCB, Biogen admit defeat in PhII lupus trial, adding to a string of late-stage failures in the field

Endpoints

Tue, 10/23/18 - 10:37 am

dapirolizumab pegol

clinical trials

Xencor’s lead drug fails a PhII test for lupus, shares slide

Endpoints

Fri, 10/5/18 - 09:54 am

clinical trials

Another setback for AstraZeneca as lupus drug fails phase 3 test

Fierce Biotech

Fri, 08/31/18 - 11:43 am

systemic lupus erythematosus

clinical trials

Lilly's lupus treatment succeeds in mid-stage trial

Reuters

Thu, 06/14/18 - 09:45 am

clinical trials

Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases

CP Wire

Mon, 04/30/18 - 09:08 pm

Gilead Sciences

rheumatoid arthritis

inflammatory bowel disease

ImmuPharma dives on late-stage lupus failure

Biopharma Dive

Wed, 04/18/18 - 11:32 am

clinical trials

GSK trials Benlysta/rituximab combo for lupus

Pharma Times

Thu, 03/22/18 - 10:31 pm

clinical trials

J&J's Stelara shows promise against lupus in study

Yahoo/Reuters

Sun, 11/5/17 - 09:28 am

clinical trials

An Exciting New Drug Is in Clinical Trials for Aurinia Pharmaceuticals

Motley Fool

Wed, 07/26/17 - 12:07 am

clinical trials

Aurinia Pharmaceuticals

Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta

Endpoints

Mon, 07/24/17 - 10:40 am

Samsung Bioepis

Celgene’s oral lupus candidate shows ‘trend to improvement’ in small test

Fierce Biotech

Thu, 06/15/17 - 09:42 am

clinical trials

Benlysta maker GSK drafts soccer star Boxx to get lupus patients talking

Fierce Pharma

Mon, 04/17/17 - 11:11 am

Did Merck KGaA’s aging atacicept just fail a PhIIb lupus trial? Well, yes, but…

Endpoints

Mon, 11/14/16 - 11:16 am

clinical trials

Anthera shares slump after lupus trial failure

BioPharma Dive

Sat, 11/12/16 - 09:06 am

Facing questions on patient deaths, Aurinia shares crater in wake of PhIIb

Endpoints

Mon, 08/15/16 - 10:01 am

clinical trials

Biogen sneaks previously unknown lupus drug into the clinic

Fierce Biotech

Wed, 07/13/16 - 02:10 pm

Promising Lupus Drug From XTL Could Be Life Changer In Projected $4 Billion Market

Seeking Alpha

Wed, 06/1/16 - 10:50 am

XTL Bipharmaceuticals

Pages